X0306 4 2022-11-30 0001677077 Alzamend Neuro, Inc. ALZN 0001327261 CRAGUN KENNETH S 3500 LENOX ROAD NE, SUITE 1500 ATLANTA GA 30326 false true false false SVP of Finance Stock Option (Right to Buy) 1.50 2029-11-17 Common Stock 1000000 0 D Stock Option (Right to Buy) 1.50 2028-12-14 Common Stock 1500000 1500000 D Mr. Cragun was granted options, exercisable for 10 years, to purchase 1,000,000 shares of the Issuer's common stock, of which (i) 50% would vest if the Issuer's common stock closed at or above $10.00 per share for 90 consecutive trading days, and (ii) 10% would vest for each $2.00 per share increment above $10.00 per share for 90 consecutive trading days, with 100% vesting if the Issuer's common stock closed at or above $20.00 per share for 90 consecutive trading days. After November 27, 2026, the number of any unvested shares subject to the option would decrease by 25%. On November 22, 2022, the Issuer modified the vesting criteria of these options to reduce the price targets, which were previously between $10.00 and $40.00 per share, and to extend the period of time for vesting before the 25% of unvested shares subject to the option would be decreased. The stock options vest ratably over 48 months beginning on December 15, 2018. /s/ Kenneth S. Cragun 2022-11-30